Montelukast Sodium Tablet, Chewable
Product Images NDC 31722-727

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 31722-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing the change in height (cm) over weeks on treatment for montelukast sodium chewable tablets compared to beclomethasone and placebo. The x-axis represents weeks on treatment from 0 to 52, and the y-axis represents change in height from -3 to 7 cm. Three data lines with error bars show growth trends over time for the three groups.*

FDA Label Image

Camberlogo

FDA Label Image

Figure2 (Figure2)

A line graph displaying the mean percent change from baseline over 15 weeks in treatment for two groups: placebo and montelukast sodium. The x-axis represents weeks in treatment, with data points at weeks 0, 3, 6, 9, 12, and 15. The y-axis shows the mean percent change from baseline. The montelukast sodium group shows a steady increase in percent change, peaking around week 12 before a decline during a washout period, while the placebo group shows a smaller, gradual increase and stabilization over time.*

FDA Label Image

Montelukastsodium4mg30scount

Montelukast Sodium Chewable Tablets 4 mg by Camber Pharmaceuticals, Inc. The label indicates a 30-tablet package for pediatric use, ages 2 to 5 years. It includes dosage information, storage instructions (20°C to 25°C), and a warning for phenylketonurics about phenylalanine content. The label shows an NDC barcode and manufacturer details with a blank area for batch coding.*

FDA Label Image

Montelukastsodium5mg30scount

Montelukast Sodium Chewable Tablets 5 mg, oral pediatric tablets labeled for patients 6 to 14 years of age. The label shows 30 tablets per bottle. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ. The label includes dosing and storage instructions, a warning about phenylalanine content, and contact information for medication guides.*

FDA Label Image

Structure (Structure)

Chemical structure of montelukast sodium illustrating the arrangement of its atoms and bonds, including distinctive rings and side groups as part of its molecular composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.